Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. (SRNE) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 153 transactions totaling $31.9M, demonstrating a bearish sentiment with -$3.0M in net insider flow. The most recent transaction on Dec 21, 2022 involved a transaction of 300 shares valued at $1.6K.
SRNE Insider Activity Summary
Who Is Buying SRNE Stock?
No significant insider buying has been recorded for SRNE in the recent period.
Who Is Selling SRNE Stock?
No significant insider selling has been recorded for SRNE in the recent period.
Is Sorrento Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SRNE is bearish with an Insider Alignment Score of 45/100 and a net flow of -$3.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SRNE Frequently Asked Questions
Understanding SRNE Insider Activity
Insider trading at Sorrento Therapeutics, Inc. (SRNE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading SRNE stock, having executed 153 transactions in the past 90 days. The most active insider is Nana Gu (Executive), who has made 2 transactions totaling $5.2M.
Related Tools
Track Sorrento Therapeutics, Inc. Insider Activity
Get notified when executives and directors at SRNE file new Form 4 transactions